Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 |
filingDate |
1994-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_819cf4966e158678bdf591c5da7d0959 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73cfc11d5218d25ae3654e9bbdde1e4a |
publicationDate |
1996-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BG-60939-B2 |
titleOfInvention |
HUMAN IMMUNE INTERFERON |
abstract |
Interferon is produced by recombinant DNA technology using any assortment of expression vector and host cultures. Recombinant human immune gamma-interferon (ifn) is isolated and characterized by its DNA and amino acid sequences, physical affinities and biological activity. There are also types of ds-ss-tyr-sys. |
priorityDate |
1985-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |